Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Basal Cell Nevus Syndrome 3 Carcinoma, Basal Cell 2 Skin Neoplasms 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1

Interventions

pembrolizumab 23 Nivolumab 22 aldesleukin 21 Cyclophosphamide 20 Ipilimumab 17 Interleukin-2 17 fludarabine 15 fludarabine phosphate 14 cemiplimab 12 Radiotherapy 7 Fluorouracil 7 Dacarbazine 6 binimetinib 5 Vemurafenib 5 Temozolomide 5 Surgical Procedures, Operative 5 Sirolimus 5 Radiation 5 Biopsy 5 Aminolevulinic Acid 5 encorafenib 4 dabrafenib 4 Photochemotherapy 4 Educational Status 4 trametinib 3 sonidegib 3 montanide ISA 51 3 avelumab 3 Tacrolimus 3 Sodium Chloride 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Skin Neoplasms × gusacitinib × Clear all

NCT02550678 2018-06-06

ASN-002-001

Ascend Biopharmaceuticals Ltd

Phase 1/2 Completed

Basal Cell Nevus Syndrome, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡